THE Food and Drug Administration (FDA) of the Philippines has announced that it is actively overseeing and verifying Nestlé Philippines’ voluntary recall of specific batches of NAN OPTIPRO and NANKID OPTIPRO infant formula products. This precautionary measure follows the identification of a potential safety and quality issue.
The voluntary recall was initiated after a reported incident involving a raw material from the manufacturer’s supplier. The FDA acknowledges that there are no established food safety limits or regulations for the identified raw material.
The agency is continuing its investigation to determine the scope of the issue and assess any potential impact on safety.
The FDA advises consumers to check the batch numbers of the product, immediately discontinue use of any affected product, and follow the recall instructions provided by the manufacturer. Consumers can check the product batch number on the website: https://www.parenteam.com.ph/voluntary-precautionary-recall.
To date, there have been no reports of illness or adverse events associated with the recalled products.
“At this time, the FDA has not received any reports of illness or adverse events associated with the recalled products. While no adverse events have been reported, the FDA fully supports this precautionary action to protect public health, especially infants and young children,” the FDA stated.
The FDA will continue to conduct inspections and analyses to ensure the safety and quality of products on the market.
metrosundaily
